Evaluation of Body Composition and Biochemical Parameters in Adult Phenylketonuria.


Journal

Nutrients
ISSN: 2072-6643
Titre abrégé: Nutrients
Pays: Switzerland
ID NLM: 101521595

Informations de publication

Date de publication:
02 Oct 2024
Historique:
received: 14 09 2024
revised: 24 09 2024
accepted: 26 09 2024
medline: 16 10 2024
pubmed: 16 10 2024
entrez: 16 10 2024
Statut: epublish

Résumé

Phenylketonuria is a hereditary metabolic disorder characterized by a deficiency of phenylalanine hydroxylase. The main treatment for PKU is a phenylalanine-restricted diet. The exclusion of protein rich natural foods and inclusion of low-Phe substitutes may give rise to an imbalanced diet, and the increased risk of overweight and obesity in PKU is a cause for concern. We aimed to evaluate the body composition and nutritional biochemical biomarkers in adult PKU patients who are on Phe-restricted and essential amino acid-supplemented nutrition therapy and to investigate the relationships between these parameters and patient gender, adherence to dietary therapy, and disease type, defined as mild or classic PKU. The study group comprised 37 PKU patients and 26 healthy siblings as controls. The participants were assessed based on an analysis of anthropometric parameters, body composition, and biochemical test results. PKU patients do not have a higher incidence of overweight and obesity than healthy controls, the proportion of energy derived from carbohydrates in their diets was below the recommended level, and their total energy intake was below the recommended daily allowance. It was remarkable that patients with a treatment adherence ratio of <50% displayed a higher prevalence of overweight and abdominal obesity in comparison to those with a more favorable treatment adherence ratio. In view of the growing prevalence of overweight in the general population, PKU patients should be kept under close long-term follow-up. Particularly in the group with low treatment compliance, more caution should be taken in terms of adverse outcomes.

Sections du résumé

BACKGROUND/OBJECTIVES OBJECTIVE
Phenylketonuria is a hereditary metabolic disorder characterized by a deficiency of phenylalanine hydroxylase. The main treatment for PKU is a phenylalanine-restricted diet. The exclusion of protein rich natural foods and inclusion of low-Phe substitutes may give rise to an imbalanced diet, and the increased risk of overweight and obesity in PKU is a cause for concern. We aimed to evaluate the body composition and nutritional biochemical biomarkers in adult PKU patients who are on Phe-restricted and essential amino acid-supplemented nutrition therapy and to investigate the relationships between these parameters and patient gender, adherence to dietary therapy, and disease type, defined as mild or classic PKU.
METHODS METHODS
The study group comprised 37 PKU patients and 26 healthy siblings as controls. The participants were assessed based on an analysis of anthropometric parameters, body composition, and biochemical test results.
RESULTS RESULTS
PKU patients do not have a higher incidence of overweight and obesity than healthy controls, the proportion of energy derived from carbohydrates in their diets was below the recommended level, and their total energy intake was below the recommended daily allowance. It was remarkable that patients with a treatment adherence ratio of <50% displayed a higher prevalence of overweight and abdominal obesity in comparison to those with a more favorable treatment adherence ratio.
CONCLUSIONS CONCLUSIONS
In view of the growing prevalence of overweight in the general population, PKU patients should be kept under close long-term follow-up. Particularly in the group with low treatment compliance, more caution should be taken in terms of adverse outcomes.

Identifiants

pubmed: 39408322
pii: nu16193355
doi: 10.3390/nu16193355
pii:
doi:

Substances chimiques

Phenylalanine 47E5O17Y3R
Biomarkers 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Mehmet Cihan Balci (MC)

Division of Nutrition and Metabolism, Istanbul Faculty of Medicine, Children's Hospital, Istanbul University, 34093 Istanbul, Turkey.

Meryem Karaca (M)

Division of Nutrition and Metabolism, Istanbul Faculty of Medicine, Children's Hospital, Istanbul University, 34093 Istanbul, Turkey.

Dilek Gunes (D)

Division of Nutrition and Metabolism, Istanbul Faculty of Medicine, Children's Hospital, Istanbul University, 34093 Istanbul, Turkey.

Huseyin Kutay Korbeyli (HK)

Division of Nutrition and Metabolism, Istanbul Faculty of Medicine, Children's Hospital, Istanbul University, 34093 Istanbul, Turkey.

Arzu Selamioglu (A)

Division of Nutrition and Metabolism, Istanbul Faculty of Medicine, Children's Hospital, Istanbul University, 34093 Istanbul, Turkey.

Gulden Gokcay (G)

Division of Nutrition and Metabolism, Istanbul Faculty of Medicine, Children's Hospital, Istanbul University, 34093 Istanbul, Turkey.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH